John W. Kozarich, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 894 shares at $191.00 ($175K) on 2026-02-02, disclosed to the SEC on 2026-02-04.
Open-market sale of $175k LGND by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $191.00 | 39 | $7K | 4.2% |
| 2 | $192.18 | 1 | $192 | 0.1% |
| 3 | $195.60 | 23 | $4K | 2.6% |
| 4 | $195.61 | 23 | $4K | 2.6% |
| 5 | $196.36 | 381 | $75K | 42.7% |
| 6 | $196.36 | 381 |
| $75K |
| 42.7% |
| 7 | $197.19 | 23 | $5K | 2.6% |
| 8 | $197.20 | 23 | $5K | 2.6% |
| Total | $196.13 avg | 894 | $175K | 100% |
| Filing → |
| LGND | SELL | 2026-03-04 | $179K | — | Filing → |
| LGND | SELL | 2026-01-06 | $173K | — | Filing → |
| LGND | SELL | 2025-12-03 | $91K | — | Filing → |